U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C175H300N56O51
Molecular Weight 4004.606
Optical Activity UNSPECIFIED
Defined Stereocenters 35 / 35
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SEMPARATIDE

SMILES

CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(N)=O

InChI

InChIKey=BLQSIKSVAXFNRH-ZMWZJJJDSA-N
InChI=1S/C175H300N56O51/c1-24-93(20)138(230-169(279)127(80-233)227-143(253)101(37-26-30-56-177)201-130(237)78-196-142(252)100(36-25-29-55-176)202-165(275)124(73-135(246)247)226-164(274)122(71-98-76-191-82-198-98)223-162(272)120(69-91(16)17)220-160(270)117(66-88(10)11)216-151(261)107(43-49-128(181)235)209-163(273)121(70-97-75-190-81-197-97)222-154(264)112(48-54-134(244)245)212-168(278)126(79-232)228-170(280)137(92(18)19)229-141(251)94(21)180)171(281)213-108(44-50-129(182)236)152(262)225-125(74-136(248)249)166(276)221-113(62-84(2)3)155(265)207-106(42-35-61-195-175(188)189)145(255)205-104(40-33-59-193-173(184)185)144(254)206-105(41-34-60-194-174(186)187)146(256)208-111(47-53-133(242)243)153(263)217-118(67-89(12)13)159(269)219-115(64-86(6)7)157(267)211-109(45-51-131(238)239)149(259)203-102(38-27-31-57-178)147(257)214-116(65-87(8)9)158(268)218-114(63-85(4)5)156(266)210-110(46-52-132(240)241)150(260)204-103(39-28-32-58-179)148(258)215-119(68-90(14)15)161(271)224-123(72-99-77-192-83-199-99)167(277)231-139(96(23)234)172(282)200-95(22)140(183)250/h75-77,81-96,100-127,137-139,232-234H,24-74,78-80,176-180H2,1-23H3,(H2,181,235)(H2,182,236)(H2,183,250)(H,190,197)(H,191,198)(H,192,199)(H,196,252)(H,200,282)(H,201,237)(H,202,275)(H,203,259)(H,204,260)(H,205,255)(H,206,254)(H,207,265)(H,208,256)(H,209,273)(H,210,266)(H,211,267)(H,212,278)(H,213,281)(H,214,257)(H,215,258)(H,216,261)(H,217,263)(H,218,268)(H,219,269)(H,220,270)(H,221,276)(H,222,264)(H,223,272)(H,224,271)(H,225,262)(H,226,274)(H,227,253)(H,228,280)(H,229,251)(H,230,279)(H,231,277)(H,238,239)(H,240,241)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H4,184,185,193)(H4,186,187,194)(H4,188,189,195)/t93-,94-,95-,96+,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,137-,138-,139-/m0/s1

HIDE SMILES / InChI

Molecular Formula C175H300N56O51
Molecular Weight 4004.606
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 35 / 35
E/Z Centers 0
Optical Activity UNSPECIFIED

Semparatide (previously known as RS-66271) was developed as an analog of parathyroid hormone-related protein (PTHrP) with shortening the time for fracture healing. Experiments on animals have shown that this compound was an effective therapy for preventing impaired bone healing caused by prednisone. Clinical trials with postmenopausal osteoporotic women have revealed that semparatide cause sustained increases in the spine. However, further, development appears to have been discontinued by Roche.

Approval Year

PubMed

PubMed

TitleDatePubMed
USAN Council. List No.421. New names. Semparatide acetate.
1999-11
Comparison of recombinant human PTH(1-34) (LY333334) with a C-terminally substituted analog of human PTH-related protein(1-34) (RS-66271): In vitro activity and in vivo pharmacological effects in rats.
1999-02
Conformational studies of RS-66271, an analog of parathyroid hormone-related protein with pronounced bone anabolic activity.
1997-09-12
RS-66271, a C-terminally substituted analog of human parathyroid hormone-related protein (1-34), increases trabecular and cortical bone in ovariectomized, osteopenic rats.
1996-12
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:22:33 GMT 2025
Edited
by admin
on Mon Mar 31 22:22:33 GMT 2025
Record UNII
5924BIZ23H
Record Status FAILED
Record Version
  • Download
Name Type Language
SEMPARATIDE
INN   WHO-DD  
INN  
Official Name English
RS-66271
Preferred Name English
ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-GLU-LEU-LEU-GLU-LYS-LEU-LEU-GLU-LYS-LEU-HIS-THR-ALA-NH2
Common Name English
Semparatide [WHO-DD]
Common Name English
semparatide [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1185
Created by admin on Mon Mar 31 22:22:33 GMT 2025 , Edited by admin on Mon Mar 31 22:22:33 GMT 2025
Code System Code Type Description
CAS
154906-40-8
Created by admin on Mon Mar 31 22:22:33 GMT 2025 , Edited by admin on Mon Mar 31 22:22:33 GMT 2025
PRIMARY
FDA UNII
5924BIZ23H
Created by admin on Mon Mar 31 22:22:33 GMT 2025 , Edited by admin on Mon Mar 31 22:22:33 GMT 2025
PRIMARY
SMS_ID
300000025275
Created by admin on Mon Mar 31 22:22:33 GMT 2025 , Edited by admin on Mon Mar 31 22:22:33 GMT 2025
PRIMARY
ChEMBL
CHEMBL2103974
Created by admin on Mon Mar 31 22:22:33 GMT 2025 , Edited by admin on Mon Mar 31 22:22:33 GMT 2025
PRIMARY
INN
7796
Created by admin on Mon Mar 31 22:22:33 GMT 2025 , Edited by admin on Mon Mar 31 22:22:33 GMT 2025
PRIMARY
NCI_THESAURUS
C152332
Created by admin on Mon Mar 31 22:22:33 GMT 2025 , Edited by admin on Mon Mar 31 22:22:33 GMT 2025
PRIMARY
PUBCHEM
16131055
Created by admin on Mon Mar 31 22:22:33 GMT 2025 , Edited by admin on Mon Mar 31 22:22:33 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY